Effect of milrinone on the inflammatory response and NF-kB activation in renal ischemia-reperfusion injury in mice

Milrinone increases intracellular adenosine 3',5'-cyclic monophosphate concentration and enhances vascular relaxation. Nuclear factor-kappa B (NF-kB) plays a key role in inflammatory responses during ischemia-reperfusion (I/R) injury. We aimed to investigate the effect of milrinone on the...

Full description

Saved in:
Bibliographic Details
Published inKorean journal of anesthesiology Vol. 66; no. 2; pp. 136 - 142
Main Authors Jung, Hong Soo, Joo, Jin-Deok, Kim, Dae-Woo, In, Jang Hyeok, Roh, Misun, Jeong, Jong-Tae, Noh, Seung June, Choi, Jin Woo
Format Journal Article
LanguageEnglish
Published Korea (South) The Korean Society of Anesthesiologists 01.02.2014
Korean Society of Anesthesiologists
대한마취통증의학회
Subjects
Online AccessGet full text
ISSN2005-6419
2005-7563
DOI10.4097/kjae.2014.66.2.136

Cover

Abstract Milrinone increases intracellular adenosine 3',5'-cyclic monophosphate concentration and enhances vascular relaxation. Nuclear factor-kappa B (NF-kB) plays a key role in inflammatory responses during ischemia-reperfusion (I/R) injury. We aimed to investigate the effect of milrinone on the inflammatory responses and NF-kB activation in renal I/R injury in mice. Thirty C57BL/6 mice were allocated into 3 groups. In group S (n = 10), only right nephrectomy was done. In group C (n = 10), the left kidney was subjected to 30 min of ischemia after right nephrectomy. In group M (n = 10), milrinone (5 µg/kg) was administered before ischemia. After 24 hours of reperfusion, the serum creatinine was measured, kidney samples were obtained for histology, and expressions of NF-kB and proinflammatory cytokines were analyzed. In group C, the serum creatinine concentration was markedly elevated, compared with group S. Creatinine concentration in group M was also elevated, but it was significantly lower than that in group C. Histologic evidence of renal damage was severe in group C, but it was improved in group M. In groups C and M, expression of NF-kB, tumor necrosis factor-α (TNF-α), intercellular adhesion molecule-1 (ICAM-1), monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-2 (MIP-2) mRNA increased significantly compared with group S (P < 0.05). But group M showed a lower expression of NF-kB, TNF-α, ICAM-1, MCP-1 and MIP-2 mRNA than group C (P < 0.05). Milrinone treatment attenuates the renal inflammatory response and activation of NF-kB, resulting in improvement of renal function and tissue injury.
AbstractList BackgroundMilrinone increases intracellular adenosine 3',5'-cyclic monophosphate concentration and enhances vascular relaxation. Nuclear factor-kappa B (NF-kB) plays a key role in inflammatory responses during ischemia-reperfusion (I/R) injury. We aimed to investigate the effect of milrinone on the inflammatory responses and NF-kB activation in renal I/R injury in mice.MethodsThirty C57BL/6 mice were allocated into 3 groups. In group S (n = 10), only right nephrectomy was done. In group C (n = 10), the left kidney was subjected to 30 min of ischemia after right nephrectomy. In group M (n = 10), milrinone (5 µg/kg) was administered before ischemia. After 24 hours of reperfusion, the serum creatinine was measured, kidney samples were obtained for histology, and expressions of NF-kB and proinflammatory cytokines were analyzed.ResultsIn group C, the serum creatinine concentration was markedly elevated, compared with group S. Creatinine concentration in group M was also elevated, but it was significantly lower than that in group C. Histologic evidence of renal damage was severe in group C, but it was improved in group M. In groups C and M, expression of NF-kB, tumor necrosis factor-α (TNF-α), intercellular adhesion molecule-1 (ICAM-1), monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-2 (MIP-2) mRNA increased significantly compared with group S (P < 0.05). But group M showed a lower expression of NF-kB, TNF-α, ICAM-1, MCP-1 and MIP-2 mRNA than group C (P < 0.05).ConclusionsMilrinone treatment attenuates the renal inflammatory response and activation of NF-kB, resulting in improvement of renal function and tissue injury.
Background: Milrinone increases intracellular adenosine 3',5'-cyclic monophosphate concentration and enhances vascular relaxation. Nuclear factor-kappa B (NF-kB) plays a key role in inflammatory responses during ischemia-reperfusion (I/R) injury. We aimed to investigate the effect of milrinone on the inflammatory responses and NF-kB activation in renal I/R injury in mice. Methods: Thirty C57BL/6 mice were allocated into 3 groups. In group S (n = 10), only right nephrectomy was done. In group C (n = 10), the left kidney was subjected to 30 min of ischemia after right nephrectomy. In group M (n = 10), milrinone (5 μg/kg) was administered before ischemia. After 24 hours of reperfusion, the serum creatinine was measured, kidney samples were obtained for histology, and expressions of NF-kB and proinflammatory cytokines were analyzed. Results: In group C, the serum creatinine concentration was markedly elevated, compared with group S. Creatinine concentration in group M was also elevated, but it was significantly lower than that in group C. Histologic evidence of renal damage was severe in group C, but it was improved in group M. In groups C and M, expression of NF-kB, tumor necrosis factor-α (TNF-α), intercellular adhesion molecule-1 (ICAM-1), monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-2 (MIP-2) mRNA increased significantly compared with group S (P < 0.05). But group M showed a lower expression of NF-kB, TNF-α, ICAM-1, MCP-1 and MIP-2 mRNA than group C (P < 0.05). Conclusions: Milrinone treatment attenuates the renal inflammatory response and activation of NF-kB, resulting in improvement of renal function and tissue injury. KCI Citation Count: 1
Milrinone increases intracellular adenosine 3',5'-cyclic monophosphate concentration and enhances vascular relaxation. Nuclear factor-kappa B (NF-kB) plays a key role in inflammatory responses during ischemia-reperfusion (I/R) injury. We aimed to investigate the effect of milrinone on the inflammatory responses and NF-kB activation in renal I/R injury in mice.BACKGROUNDMilrinone increases intracellular adenosine 3',5'-cyclic monophosphate concentration and enhances vascular relaxation. Nuclear factor-kappa B (NF-kB) plays a key role in inflammatory responses during ischemia-reperfusion (I/R) injury. We aimed to investigate the effect of milrinone on the inflammatory responses and NF-kB activation in renal I/R injury in mice.Thirty C57BL/6 mice were allocated into 3 groups. In group S (n = 10), only right nephrectomy was done. In group C (n = 10), the left kidney was subjected to 30 min of ischemia after right nephrectomy. In group M (n = 10), milrinone (5 µg/kg) was administered before ischemia. After 24 hours of reperfusion, the serum creatinine was measured, kidney samples were obtained for histology, and expressions of NF-kB and proinflammatory cytokines were analyzed.METHODSThirty C57BL/6 mice were allocated into 3 groups. In group S (n = 10), only right nephrectomy was done. In group C (n = 10), the left kidney was subjected to 30 min of ischemia after right nephrectomy. In group M (n = 10), milrinone (5 µg/kg) was administered before ischemia. After 24 hours of reperfusion, the serum creatinine was measured, kidney samples were obtained for histology, and expressions of NF-kB and proinflammatory cytokines were analyzed.In group C, the serum creatinine concentration was markedly elevated, compared with group S. Creatinine concentration in group M was also elevated, but it was significantly lower than that in group C. Histologic evidence of renal damage was severe in group C, but it was improved in group M. In groups C and M, expression of NF-kB, tumor necrosis factor-α (TNF-α), intercellular adhesion molecule-1 (ICAM-1), monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-2 (MIP-2) mRNA increased significantly compared with group S (P < 0.05). But group M showed a lower expression of NF-kB, TNF-α, ICAM-1, MCP-1 and MIP-2 mRNA than group C (P < 0.05).RESULTSIn group C, the serum creatinine concentration was markedly elevated, compared with group S. Creatinine concentration in group M was also elevated, but it was significantly lower than that in group C. Histologic evidence of renal damage was severe in group C, but it was improved in group M. In groups C and M, expression of NF-kB, tumor necrosis factor-α (TNF-α), intercellular adhesion molecule-1 (ICAM-1), monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-2 (MIP-2) mRNA increased significantly compared with group S (P < 0.05). But group M showed a lower expression of NF-kB, TNF-α, ICAM-1, MCP-1 and MIP-2 mRNA than group C (P < 0.05).Milrinone treatment attenuates the renal inflammatory response and activation of NF-kB, resulting in improvement of renal function and tissue injury.CONCLUSIONSMilrinone treatment attenuates the renal inflammatory response and activation of NF-kB, resulting in improvement of renal function and tissue injury.
Milrinone increases intracellular adenosine 3',5'-cyclic monophosphate concentration and enhances vascular relaxation. Nuclear factor-kappa B (NF-kB) plays a key role in inflammatory responses during ischemia-reperfusion (I/R) injury. We aimed to investigate the effect of milrinone on the inflammatory responses and NF-kB activation in renal I/R injury in mice. Thirty C57BL/6 mice were allocated into 3 groups. In group S (n = 10), only right nephrectomy was done. In group C (n = 10), the left kidney was subjected to 30 min of ischemia after right nephrectomy. In group M (n = 10), milrinone (5 µg/kg) was administered before ischemia. After 24 hours of reperfusion, the serum creatinine was measured, kidney samples were obtained for histology, and expressions of NF-kB and proinflammatory cytokines were analyzed. In group C, the serum creatinine concentration was markedly elevated, compared with group S. Creatinine concentration in group M was also elevated, but it was significantly lower than that in group C. Histologic evidence of renal damage was severe in group C, but it was improved in group M. In groups C and M, expression of NF-kB, tumor necrosis factor-α (TNF-α), intercellular adhesion molecule-1 (ICAM-1), monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-2 (MIP-2) mRNA increased significantly compared with group S (P < 0.05). But group M showed a lower expression of NF-kB, TNF-α, ICAM-1, MCP-1 and MIP-2 mRNA than group C (P < 0.05). Milrinone treatment attenuates the renal inflammatory response and activation of NF-kB, resulting in improvement of renal function and tissue injury.
Author Jung, Hong Soo
Kim, Dae-Woo
In, Jang Hyeok
Roh, Misun
Joo, Jin-Deok
Choi, Jin Woo
Jeong, Jong-Tae
Noh, Seung June
AuthorAffiliation 1 Department of Anesthesiology and Pain Medicine, College of Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea
2 The Research Institute of Medical Science, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea
AuthorAffiliation_xml – name: 2 The Research Institute of Medical Science, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea
– name: 1 Department of Anesthesiology and Pain Medicine, College of Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea
Author_xml – sequence: 1
  givenname: Hong Soo
  surname: Jung
  fullname: Jung, Hong Soo
  organization: Department of Anesthesiology and Pain Medicine, College of Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea
– sequence: 2
  givenname: Jin-Deok
  surname: Joo
  fullname: Joo, Jin-Deok
  organization: Department of Anesthesiology and Pain Medicine, College of Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea
– sequence: 3
  givenname: Dae-Woo
  surname: Kim
  fullname: Kim, Dae-Woo
  organization: Department of Anesthesiology and Pain Medicine, College of Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea
– sequence: 4
  givenname: Jang Hyeok
  surname: In
  fullname: In, Jang Hyeok
  organization: Department of Anesthesiology and Pain Medicine, College of Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea
– sequence: 5
  givenname: Misun
  surname: Roh
  fullname: Roh, Misun
  organization: Department of Anesthesiology and Pain Medicine, College of Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea
– sequence: 6
  givenname: Jong-Tae
  surname: Jeong
  fullname: Jeong, Jong-Tae
  organization: Department of Anesthesiology and Pain Medicine, College of Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea
– sequence: 7
  givenname: Seung June
  surname: Noh
  fullname: Noh, Seung June
  organization: The Research Institute of Medical Science, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea
– sequence: 8
  givenname: Jin Woo
  surname: Choi
  fullname: Choi, Jin Woo
  organization: Department of Anesthesiology and Pain Medicine, College of Medicine, St. Vincent's Hospital, The Catholic University of Korea, Suwon, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24624272$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001851038$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9kk1v1DAQhiNUREvpH-CAcuSSrb9iJxekUrWwUgUSKmdr4oy73k3sxc5W6r_Hu2kL5YAvY3meeeeVZ94WRz54LIr3lCwEadX5Zg24YISKhZQLtqBcvipOGCF1pWrJjx7vUtD2uDhLaU3y4ZwQyd4Ux0xIJphiJ0W8shbNVAZbjm6Ibt-lDL6cVlg6bwcYR5hCfCgjpm3wCUvwffntutp8LsFM7h4ml3HnM-BhKF0yKxwdVBG3GO0uzdn1LktkaHQG3xWvLQwJzx7jafHz-ur28mt18_3L8vLipjK1VFOF1IhsWEmkIDpuaNta1pmul8wo3nfAuDKk71jLmcHWUsulIH3dKEUIo4qfFh9nXR-t3hinA7hDvAt6E_XFj9ulVqymNcnockb7AGu9jW6E-HDgDw8h3mmIkzMDagkEul4hsdiIBgSwviG26QD6RlnArPVp1truuhF7g36KMLwQfZnxbpUt3WveikYI-sf3NoZfO0yTHvOv4jCAx7BLOhtWqhWtYBn98Hev5yZP880AmwETQ0oR7TNCid7vkd7vkd7vkZZSM533KBc1_xQZNx3mnP264X-lvwG7nc_1
CitedBy_id crossref_primary_10_1016_j_tox_2015_10_010
crossref_primary_10_1038_ncomms14181
crossref_primary_10_1007_s00405_019_05417_5
crossref_primary_10_1097_WNR_0000000000000419
crossref_primary_10_3389_fphar_2021_561237
crossref_primary_10_1016_j_lfs_2023_121435
crossref_primary_10_1038_s41401_018_0160_1
crossref_primary_10_1039_D1MD00131K
crossref_primary_10_1097_WNR_0000000000000618
crossref_primary_10_3390_biom11101549
crossref_primary_10_4097_kjae_2014_66_2_93
crossref_primary_10_1080_08941939_2017_1343880
crossref_primary_10_1177_1535370219855399
crossref_primary_10_1016_j_avsg_2020_06_050
crossref_primary_10_1016_j_toxlet_2018_05_003
crossref_primary_10_2147_DDDT_S267856
crossref_primary_10_1155_2021_9098145
crossref_primary_10_1016_j_lfs_2021_119843
crossref_primary_10_1080_00207454_2023_2286209
crossref_primary_10_1016_j_intimp_2016_08_032
crossref_primary_10_1111_and_14128
crossref_primary_10_1371_journal_pone_0117004
crossref_primary_10_1016_j_gene_2016_12_026
crossref_primary_10_18632_aging_202889
crossref_primary_10_1016_j_lfs_2022_120799
crossref_primary_10_1016_j_wneu_2020_12_021
crossref_primary_10_15407_ubj93_01_051
crossref_primary_10_1016_j_transproceed_2016_11_043
crossref_primary_10_1007_s00210_023_02476_8
crossref_primary_10_1590_1517_869220172303159519
crossref_primary_10_3390_molecules25081817
crossref_primary_10_1016_j_pharmthera_2016_03_015
crossref_primary_10_2147_NDT_S240698
crossref_primary_10_1053_j_jvca_2018_04_032
crossref_primary_10_1016_j_toxrep_2015_07_019
crossref_primary_10_1093_jpp_rgaf002
Cites_doi 10.3109/00365513.2013.796591
10.1016/0888-6296(90)90226-6
10.1016/j.jss.2008.07.004
10.1002/hep.21497
10.1152/ajpheart.00796.2000
10.1016/S0006-2952(02)01523-X
10.1016/j.jss.2006.05.038
10.1055/s-0038-1655981
10.1016/j.bbrc.2006.10.006
10.1038/sj.bjp.0706495
10.1096/fj.01-0739fje
10.1097/00007890-198303000-00002
10.1172/JCI119457
10.1016/S0022-5347(17)42037-4
10.4097/kjae.2007.53.2.229
10.1152/ajplung.00429.2002
10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6
10.1186/1479-5876-7-67
10.1016/j.transproceed.2011.03.009
10.1152/ajplung.00539.2005
10.1097/00003246-200201001-00003
10.1111/j.1478-3231.2006.01327.x
10.1074/jbc.M111.225631
10.1038/cr.2009.137
ContentType Journal Article
Copyright Copyright © the Korean Society of Anesthesiologists, 2014 2014
Copyright_xml – notice: Copyright © the Korean Society of Anesthesiologists, 2014 2014
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
ACYCR
DOI 10.4097/kjae.2014.66.2.136
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 2005-7563
EndPage 142
ExternalDocumentID oai_kci_go_kr_ARTI_725150
oai_doaj_org_article_6a0abd7e0fe848a4a2d80f8baad87fae
PMC3948441
24624272
10_4097_kjae_2014_66_2_136
Genre Journal Article
GrantInformation_xml – fundername: The St. Vincent's hospital, research institute of medical science, Korea
GroupedDBID 5-W
53G
8JR
8XY
9ZL
AAYXX
ABDBF
ACUHS
ADRAZ
ALMA_UNASSIGNED_HOLDINGS
CITATION
DIK
E3Z
EBD
EF.
ESX
F5P
GROUPED_DOAJ
HYE
KQ8
M48
O5R
O5S
OK1
PGMZT
RPM
TUS
NPM
7X8
5PM
ACYCR
ID FETCH-LOGICAL-c567t-e1c433076e1a4b3c199f2bcbd62c73dba237c0db2932ce9f1f3640d5877002173
IEDL.DBID M48
ISSN 2005-6419
IngestDate Sun Mar 09 07:51:11 EDT 2025
Wed Aug 27 01:20:54 EDT 2025
Thu Aug 21 17:40:36 EDT 2025
Thu Jul 10 22:39:57 EDT 2025
Mon Jul 21 06:07:19 EDT 2025
Tue Jul 01 02:43:50 EDT 2025
Thu Apr 24 23:07:35 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Ischemia-reperfusion injury
Milrinone
Nuclear-factor-kappa B
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c567t-e1c433076e1a4b3c199f2bcbd62c73dba237c0db2932ce9f1f3640d5877002173
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
G704-000679.2014.66.2.006
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.4097/kjae.2014.66.2.136
PMID 24624272
PQID 1507794942
PQPubID 23479
PageCount 7
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_725150
doaj_primary_oai_doaj_org_article_6a0abd7e0fe848a4a2d80f8baad87fae
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3948441
proquest_miscellaneous_1507794942
pubmed_primary_24624272
crossref_primary_10_4097_kjae_2014_66_2_136
crossref_citationtrail_10_4097_kjae_2014_66_2_136
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-02-01
PublicationDateYYYYMMDD 2014-02-01
PublicationDate_xml – month: 02
  year: 2014
  text: 2014-02-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Korean journal of anesthesiology
PublicationTitleAlternate Korean J Anesthesiol
PublicationYear 2014
Publisher The Korean Society of Anesthesiologists
Korean Society of Anesthesiologists
대한마취통증의학회
Publisher_xml – name: The Korean Society of Anesthesiologists
– name: Korean Society of Anesthesiologists
– name: 대한마취통증의학회
References Fan (10.4097/kjae.2014.66.2.136_ref2) 2002; 282
Lanfear (10.4097/kjae.2014.66.2.136_ref7) 2009; 7
Nishiki (10.4097/kjae.2014.66.2.136_ref8) 2011; 43
Satoh (10.4097/kjae.2014.66.2.136_ref12) 2009; 155
Lalor (10.4097/kjae.2014.66.2.136_ref19) 2007; 45
Wan (10.4097/kjae.2014.66.2.136_ref3) 2010; 20
Levy (10.4097/kjae.2014.66.2.136_ref10) 1990; 4
Wright (10.4097/kjae.2014.66.2.136_ref25) 2007; 292
Semmler (10.4097/kjae.2014.66.2.136_ref17) 1993; 78
Comerford (10.4097/kjae.2014.66.2.136_ref14) 2002; 16
Carden (10.4097/kjae.2014.66.2.136_ref21) 2000; 190
Lee (10.4097/kjae.2014.66.2.136_ref24) 2006; 351
Rodríguez (10.4097/kjae.2014.66.2.136_ref26) 2011; 286
Joo (10.4097/kjae.2014.66.2.136_ref1) 2007; 53
Schäfer (10.4097/kjae.2014.66.2.136_ref15) 2003; 65
Bombeli (10.4097/kjae.2014.66.2.136_ref20) 1997; 77
McDougal (10.4097/kjae.2014.66.2.136_ref23) 1988; 140
Boswell-Smith (10.4097/kjae.2014.66.2.136_ref6) 2006; 147
Qiao (10.4097/kjae.2014.66.2.136_ref16) 2003; 284
Craciun (10.4097/kjae.2014.66.2.136_ref13) 2013; 73
Kume (10.4097/kjae.2014.66.2.136_ref11) 2006; 136
Jablonski (10.4097/kjae.2014.66.2.136_ref9) 1983; 35
Takada (10.4097/kjae.2014.66.2.136_ref22) 1997; 99
Senftleben (10.4097/kjae.2014.66.2.136_ref5) 2002; 30
Häcker (10.4097/kjae.2014.66.2.136_ref4) 2006; 357
Jaeschke (10.4097/kjae.2014.66.2.136_ref18) 2006; 26
19640280 - J Transl Med. 2009 Jul 29;7:67
17045613 - J Surg Res. 2006 Dec;136(2):209-18
11959643 - Am J Physiol Heart Circ Physiol. 2002 May;282(5):H1778-86
10685060 - J Pathol. 2000 Feb;190(3):255-66
9169498 - J Clin Invest. 1997 Jun 1;99(11):2682-90
9065986 - Thromb Haemost. 1997 Mar;77(3):408-23
21558270 - J Biol Chem. 2011 Jul 1;286(26):22814-24
8388363 - Immunology. 1993 Apr;78(4):520-5
11782557 - Crit Care Med. 2002 Jan;30(1 Suppl):S18-26
3057220 - J Urol. 1988 Dec;140(6):1325-30
19111324 - J Surg Res. 2009 Jul;155(1):32-9
19997086 - Cell Res. 2010 Jan;20(1):24-33
16402111 - Br J Pharmacol. 2006 Jan;147 Suppl 1:S252-7
6340272 - Transplantation. 1983 Mar;35(3):198-204
23713554 - Scand J Clin Lab Invest. 2013 Aug;73(5):407-13
17256751 - Hepatology. 2007 Feb;45(2):465-74
21693223 - Transplant Proc. 2011 Jun;43(5):1489-94
16905636 - Am J Physiol Lung Cell Mol Physiol. 2007 Jan;292(1):L125-33
12588708 - Am J Physiol Lung Cell Mol Physiol. 2003 Jun;284(6):L972-80
17052690 - Biochem Biophys Res Commun. 2006 Dec 8;351(1):118-25
12527332 - Biochem Pharmacol. 2003 Feb 1;65(3):397-405
16953830 - Liver Int. 2006 Oct;26(8):912-9
17047224 - Sci STKE. 2006 Oct 17;2006(357):re13
11919161 - FASEB J. 2002 Apr;16(6):583-5
References_xml – volume: 73
  start-page: 407
  year: 2013
  ident: 10.4097/kjae.2014.66.2.136_ref13
  publication-title: Scand J Clin Lab Invest
  doi: 10.3109/00365513.2013.796591
– volume: 4
  start-page: 7
  issue: Suppl 5
  year: 1990
  ident: 10.4097/kjae.2014.66.2.136_ref10
  publication-title: J Cardiothorac Anesth
  doi: 10.1016/0888-6296(90)90226-6
– volume: 155
  start-page: 32
  year: 2009
  ident: 10.4097/kjae.2014.66.2.136_ref12
  publication-title: J Surg Res
  doi: 10.1016/j.jss.2008.07.004
– volume: 45
  start-page: 465
  year: 2007
  ident: 10.4097/kjae.2014.66.2.136_ref19
  publication-title: Hepatology
  doi: 10.1002/hep.21497
– volume: 78
  start-page: 520
  year: 1993
  ident: 10.4097/kjae.2014.66.2.136_ref17
  publication-title: Immunology
– volume: 282
  start-page: H1778
  year: 2002
  ident: 10.4097/kjae.2014.66.2.136_ref2
  publication-title: Am J Physiol Heart Circ Physiol
  doi: 10.1152/ajpheart.00796.2000
– volume: 65
  start-page: 397
  year: 2003
  ident: 10.4097/kjae.2014.66.2.136_ref15
  publication-title: Biochem Pharmacol
  doi: 10.1016/S0006-2952(02)01523-X
– volume: 136
  start-page: 209
  year: 2006
  ident: 10.4097/kjae.2014.66.2.136_ref11
  publication-title: J Surg Res
  doi: 10.1016/j.jss.2006.05.038
– volume: 77
  start-page: 408
  year: 1997
  ident: 10.4097/kjae.2014.66.2.136_ref20
  publication-title: Thromb Haemost
  doi: 10.1055/s-0038-1655981
– volume: 351
  start-page: 118
  year: 2006
  ident: 10.4097/kjae.2014.66.2.136_ref24
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2006.10.006
– volume: 147
  start-page: S252
  issue: Suppl 1
  year: 2006
  ident: 10.4097/kjae.2014.66.2.136_ref6
  publication-title: Br J Pharmacol
  doi: 10.1038/sj.bjp.0706495
– volume: 16
  start-page: 583
  year: 2002
  ident: 10.4097/kjae.2014.66.2.136_ref14
  publication-title: FASEB J
  doi: 10.1096/fj.01-0739fje
– volume: 35
  start-page: 198
  year: 1983
  ident: 10.4097/kjae.2014.66.2.136_ref9
  publication-title: Transplantation
  doi: 10.1097/00007890-198303000-00002
– volume: 99
  start-page: 2682
  year: 1997
  ident: 10.4097/kjae.2014.66.2.136_ref22
  publication-title: J Clin Invest
  doi: 10.1172/JCI119457
– volume: 140
  start-page: 1325
  year: 1988
  ident: 10.4097/kjae.2014.66.2.136_ref23
  publication-title: J Urol
  doi: 10.1016/S0022-5347(17)42037-4
– volume: 53
  start-page: 229
  year: 2007
  ident: 10.4097/kjae.2014.66.2.136_ref1
  publication-title: Korean J Anesthesiol
  doi: 10.4097/kjae.2007.53.2.229
– volume: 284
  start-page: L972
  year: 2003
  ident: 10.4097/kjae.2014.66.2.136_ref16
  publication-title: Am J Physiol Lung Cell Mol Physiol
  doi: 10.1152/ajplung.00429.2002
– volume: 190
  start-page: 255
  year: 2000
  ident: 10.4097/kjae.2014.66.2.136_ref21
  publication-title: J Pathol
  doi: 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6
– volume: 7
  start-page: 67
  year: 2009
  ident: 10.4097/kjae.2014.66.2.136_ref7
  publication-title: J Transl Med
  doi: 10.1186/1479-5876-7-67
– volume: 43
  start-page: 1489
  year: 2011
  ident: 10.4097/kjae.2014.66.2.136_ref8
  publication-title: Transplant Proc
  doi: 10.1016/j.transproceed.2011.03.009
– volume: 292
  start-page: L125
  year: 2007
  ident: 10.4097/kjae.2014.66.2.136_ref25
  publication-title: Am J Physiol Lung Cell Mol Physiol
  doi: 10.1152/ajplung.00539.2005
– volume: 357
  start-page: re13
  year: 2006
  ident: 10.4097/kjae.2014.66.2.136_ref4
  publication-title: Sci STKE
– volume: 30
  start-page: S18
  issue: 1 Suppl
  year: 2002
  ident: 10.4097/kjae.2014.66.2.136_ref5
  publication-title: Crit Care Med
  doi: 10.1097/00003246-200201001-00003
– volume: 26
  start-page: 912
  year: 2006
  ident: 10.4097/kjae.2014.66.2.136_ref18
  publication-title: Liver Int
  doi: 10.1111/j.1478-3231.2006.01327.x
– volume: 286
  start-page: 22814
  year: 2011
  ident: 10.4097/kjae.2014.66.2.136_ref26
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M111.225631
– volume: 20
  start-page: 24
  year: 2010
  ident: 10.4097/kjae.2014.66.2.136_ref3
  publication-title: Cell Res
  doi: 10.1038/cr.2009.137
– reference: 12588708 - Am J Physiol Lung Cell Mol Physiol. 2003 Jun;284(6):L972-80
– reference: 6340272 - Transplantation. 1983 Mar;35(3):198-204
– reference: 17047224 - Sci STKE. 2006 Oct 17;2006(357):re13
– reference: 19111324 - J Surg Res. 2009 Jul;155(1):32-9
– reference: 9169498 - J Clin Invest. 1997 Jun 1;99(11):2682-90
– reference: 8388363 - Immunology. 1993 Apr;78(4):520-5
– reference: 19640280 - J Transl Med. 2009 Jul 29;7:67
– reference: 11782557 - Crit Care Med. 2002 Jan;30(1 Suppl):S18-26
– reference: 11919161 - FASEB J. 2002 Apr;16(6):583-5
– reference: 17256751 - Hepatology. 2007 Feb;45(2):465-74
– reference: 3057220 - J Urol. 1988 Dec;140(6):1325-30
– reference: 21693223 - Transplant Proc. 2011 Jun;43(5):1489-94
– reference: 19997086 - Cell Res. 2010 Jan;20(1):24-33
– reference: 21558270 - J Biol Chem. 2011 Jul 1;286(26):22814-24
– reference: 12527332 - Biochem Pharmacol. 2003 Feb 1;65(3):397-405
– reference: 16953830 - Liver Int. 2006 Oct;26(8):912-9
– reference: 10685060 - J Pathol. 2000 Feb;190(3):255-66
– reference: 17045613 - J Surg Res. 2006 Dec;136(2):209-18
– reference: 9065986 - Thromb Haemost. 1997 Mar;77(3):408-23
– reference: 16905636 - Am J Physiol Lung Cell Mol Physiol. 2007 Jan;292(1):L125-33
– reference: 23713554 - Scand J Clin Lab Invest. 2013 Aug;73(5):407-13
– reference: 17052690 - Biochem Biophys Res Commun. 2006 Dec 8;351(1):118-25
– reference: 11959643 - Am J Physiol Heart Circ Physiol. 2002 May;282(5):H1778-86
– reference: 16402111 - Br J Pharmacol. 2006 Jan;147 Suppl 1:S252-7
SSID ssj0000330062
Score 2.1188679
Snippet Milrinone increases intracellular adenosine 3',5'-cyclic monophosphate concentration and enhances vascular relaxation. Nuclear factor-kappa B (NF-kB) plays a...
BackgroundMilrinone increases intracellular adenosine 3',5'-cyclic monophosphate concentration and enhances vascular relaxation. Nuclear factor-kappa B (NF-kB)...
Background: Milrinone increases intracellular adenosine 3',5'-cyclic monophosphate concentration and enhances vascular relaxation. Nuclear factor-kappa B...
SourceID nrf
doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 136
SubjectTerms Experimental
ischemia-reperfusion injury
milrinone
nuclear-factor-kappa b
마취과학
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT1wQiNfyqIzEDaV1HMePY4tYFQ49Uak3y09It5ut0t3_z4y9Xe0iBBdOkeJxZHvG9jfx-BtCPvrYd1nytnE6KXBQtGlc70TDXIoi-xxMDZC9lBdX4tt1f72X6gtjwio9cB24U-mY81EllpMW2gnHo2ZZe-eiVtklXH2ZYXvOVFmDwU1nJZtoodqUojX1xgzSO50ubhwyZLbiRMoTjpFeB7tSIe-HvWac8p9w5-_hk3v70fwpebIFkvSsduAZeZTG52SqZMR0lelyuJ0G8O0TXY0UUB4FUwLtL8upOp1qaGyiboz0ct4szinecKj_Z0EUBPDrA_i-aTm4Zkp3acqb-1p6A4pAIUxl_4Jczb98_3zRbLMqNKGXat2kNggYHSVT64TvQmtM5j74KHlQXfSOdyqw6AEH8JBMbnMnBYu9Vqo4MN1LcoStf02oCUH0XkuFtGCmizomKQIAktDBsqn7GWkfRtWGLeU4Zr64teB6oCYsasKiJqyUllvQxIx82tW5q4Qbf5U-R2XtJJEsu7wAE7JbE7L_MqEZ-QCqtoswlPr4_LGyi8mCS_HVKkCAPQOZB0OwMAHxVMWNabW5t4ioYVEzgs_Iq2oYu-ZwgddvFJSoA5M5aO9hyTj8LCTfnREaoOqb_9HBt-QxjloNNn9HjtbTJr0HLLX2x2Xa_AIeKx7d
  priority: 102
  providerName: Directory of Open Access Journals
Title Effect of milrinone on the inflammatory response and NF-kB activation in renal ischemia-reperfusion injury in mice
URI https://www.ncbi.nlm.nih.gov/pubmed/24624272
https://www.proquest.com/docview/1507794942
https://pubmed.ncbi.nlm.nih.gov/PMC3948441
https://doaj.org/article/6a0abd7e0fe848a4a2d80f8baad87fae
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001851038
Volume 66
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Korean Journal of Anesthesiology, 2014, 66(2), , pp.136-142
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfGeOEFgfjqGJWReEMpiePYzhNiiGogsScq7c3y58japiNtJfbfc-ekFUUD8RSpviTu3dn-nXP-HSFvrK_KKFiRGRUkBCiqzkxleJab4Hm00dV9guyFOJ_xL5fV5RHZlTsaFLi-M7TDelKzbjH5-eP2PQx4wK8TZGt6N782SHhZ8IkQE4aJW_fIfViZBAZjXwe4n2ZmCN7zVGM0EXAKXtT9OZq_POZgrUqU_rACtV28C43-mVT52yo1fUQeDvCSfuj94TE5Cu0T0vUUxXQV6bJZdA1E_IGuWgrYj8JfBp9Ypm_ttOsTZgM1racX02x-RvHcQ79rC6IggE9vQG1h2ZisCzehi9t133oN5kEhLHD_lMymn759PM-GWguZq4TcZKFwHLQjRSgMt6Ur6joy66wXzMnSW8NK6XJvAR0wF-pYxFLw3FdKyhTWlM_IMfb-BaG1c7yySkgkC6tLr3wQ3AFMcSVMpqoakWKnVe0GInKsh7HQEJCgJTRaQqMltBCaabDEiLzd33PT03D8U_oMjbWXRArt9MOqu9LDiNTC5MZ6GfIYFFeGG-ZVHpU1xisZTRiR12BqPXdNuh-vVys97zQEGp-1BFxY5SCzcwQNwxK_tZg2rLZrjTgbprqasxF53jvGvjuM46EcCS3ywGUO-nvY0jbfE_V3WXMFAPbkP977kjxApfQZ5qfkeNNtwysAUBs7ThsP4zQ2xml_6xdi-xvi
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+milrinone+on+the+inflammatory+response+and+NF-kB+activation+in+renal+ischemia-reperfusion+injury+in+mice&rft.jtitle=Korean+journal+of+anesthesiology&rft.au=Jung%2C+Hong+Soo&rft.au=Joo%2C+Jin-Deok&rft.au=Kim%2C+Dae-Woo&rft.au=In%2C+Jang+Hyeok&rft.date=2014-02-01&rft.issn=2005-6419&rft.volume=66&rft.issue=2&rft.spage=136&rft_id=info:doi/10.4097%2Fkjae.2014.66.2.136&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2005-6419&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2005-6419&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2005-6419&client=summon